Log in to save to my catalogue

Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjug...

Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjug...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_186557

Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate

About this item

Full title

Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate

Publisher

Germany

Journal title

European journal of nuclear medicine and molecular imaging, 2014-03, Vol.41 (3), p.476

Language

English

Formats

Publication information

Publisher

Germany

More information

Scope and Contents

Contents

The radiolanthanide (161)Tb (T 1/2 = 6.90 days, Eβ(-) av = 154 keV) was recently proposed as a potential alternative to (177)Lu (T 1/2 = 6.71 days, Eβ(-) av = 134 keV) due to similar physical decay characteristics but additional conversion and Auger electrons that may enhance the therapeutic efficacy. The goal of this study was to compare (161)Tb a...

Alternative Titles

Full title

Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_186557

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_186557

Other Identifiers

ISSN

1619-7089

E-ISSN

1619-7089

DOI

10.1007/s00259-013-2563-z

How to access this item